Award
National Cancer Institute 5R01CA277966-04
Macrophage-based Therapy and Immune Checkpoint Blockade for Glioblastoma
Recipient
National Cancer Institute (NCI), part of the NIH
Award Amount
$368,288.00
Ceiling
$368,288.00
Awarded
December 10, 2025
Identifier
5R01CA277966-04
NIH grant awarded for research on macrophage-based therapy combined with immune checkpoint blockade to treat glioblastoma, aiming to inform future clinical trials.
Description
This is a NIH grant project focused on glioblastoma therapy involving macrophage reprogramming and immune checkpoint blockade. The project aims to assess the therapeutic impact of TAM-based therapy in combination with current ICB for GBM, with outcomes informing future clinical trials.